IP Verse

Delivery And Use Of The Crispr-Cas Systems, Vectors And Compositions For Hepatic Targeting And Therapy

Patent No. EP3011031 (titled "Delivery And Use Of The Crispr-Cas Systems, Vectors And Compositions For Hepatic Targeting And Therapy") was filed by Massachusetts Institute OF Technology on Jun 10, 2014. The application was issued on Sep 30, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PATENT BOUTIQUEFeb 23, 2021-
CRISPR THERAPEUTICSNov 13, 2020VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3011031

MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Application Number
EP14734710A
Filing Date
Jun 10, 2014
Status
Granted And Under Opposition
Aug 28, 2020
Publication Date
Sep 30, 2020
External Links
Slate, Register , Google Patents